1. CHOP VERSUS GEM‐P IN THE FIRST‐LINE TREATMENT OF T‐CELL LYMPHOMA (PTCL): INITIAL RESULTS OF THE UK NRCI PHASE II RANDOMISED CHEMO‐T TRIAL. (June 2017) Authors: Gleeson, M.; Peckitt, C.; To, Y.M.; Edwards, L.; Chau, I.; Johnson, P.; Ardeshna, K.M.; Wotherspoon, A.; Attygalle, A.; Begum, R.; Chua, S.; Zerizer, I.; Hawkes, E.A.; Macheta, M.P.; Collins, G.P.; Radford, J.A.; Forbes, A.; Hart, A.; Montoto, S.; McKay, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THE ROLE OF 18F FDG‐PET/CT IN PERIPHERAL T‐CELL LYMPHOMA (PTCL): INITIAL RESULTS OF THE UK NCRI MULTICENTRE PHASE II RANDOMISED CHEMO‐T TRIAL PET/CT SUBSTUDY. (June 2017) Authors: Gleeson, M.; Peckitt, C.; Cunningham, D.; To, Y.M.; Edwards, L.; Chau, I.; Johnson, P.; Ardeshna, K.M.; Wotherspoon, A.; Attygalle, A.; Begum, R.; Zerizer, I.; Hawkes, E.A.; Macheta, M.P.; Collins, G.P.; Radford, J.A.; Forbes, A.; Hart, A.; Montoto, S.; McKay, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗